Corrigendum to “Mechanisms of resistance against NITD-916, a direct inhibitor of Mycobacterium tuberculosis InhA” [Tuberculosis 107 (December 2017) 133–136]

In the version of this article initially published the authors omitted a funding source. The correct funding paragraph is as follows. Research reported in this publication was supported in part by NIAID of the National Institutes of Health under award numbers R01AI09918 and R01AI125160, by the Bill and Melinda Gates Foundation, under grant OPP1024038 and by Anacor Pharmaceuticals. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Source: Tuberculosis - February 8, 2018 Category: Respiratory Medicine Authors: Matthew B. McNeil, Devon Dennison, Catherine Shelton, Lindsay Flint, Aaron Korkegian, Tanya Parish Source Type: research